Copyright Reports & Markets. All rights reserved.

Global Non-prescription Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Non-prescription Drugs Market Overview

      • 1.1 Product Overview and Scope of Non-prescription Drugs
      • 1.2 Non-prescription Drugs Segment by Type
        • 1.2.1 Global Non-prescription Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Brand Drugs
        • 1.2.3 Generic Drug
      • 1.3 Non-prescription Drugs Segment by Application
        • 1.3.1 Non-prescription Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Other
      • 1.4 Global Non-prescription Drugs Market by Region
        • 1.4.1 Global Non-prescription Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Non-prescription Drugs Market Size
        • 1.5.1 Global Non-prescription Drugs Revenue (2014-2025)
        • 1.5.2 Global Non-prescription Drugs Production (2014-2025)

      2 Global Non-prescription Drugs Market Competition by Manufacturers

      • 2.1 Global Non-prescription Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Non-prescription Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Non-prescription Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Non-prescription Drugs Production Sites, Area Served, Product Types
      • 2.5 Non-prescription Drugs Market Competitive Situation and Trends
        • 2.5.1 Non-prescription Drugs Market Concentration Rate
        • 2.5.2 Non-prescription Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Non-prescription Drugs Production Market Share by Regions

      • 3.1 Global Non-prescription Drugs Production Market Share by Regions
      • 3.2 Global Non-prescription Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Non-prescription Drugs Production
        • 3.4.1 North America Non-prescription Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Non-prescription Drugs Production
        • 3.5.1 Europe Non-prescription Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Non-prescription Drugs Production (2014-2019)
        • 3.6.1 China Non-prescription Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Non-prescription Drugs Production (2014-2019)
        • 3.7.1 Japan Non-prescription Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Non-prescription Drugs Consumption by Regions

      • 4.1 Global Non-prescription Drugs Consumption by Regions
      • 4.2 North America Non-prescription Drugs Consumption (2014-2019)
      • 4.3 Europe Non-prescription Drugs Consumption (2014-2019)
      • 4.4 China Non-prescription Drugs Consumption (2014-2019)
      • 4.5 Japan Non-prescription Drugs Consumption (2014-2019)

      5 Global Non-prescription Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Non-prescription Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Non-prescription Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Non-prescription Drugs Price by Type (2014-2019)
      • 5.4 Global Non-prescription Drugs Production Growth by Type (2014-2019)

      6 Global Non-prescription Drugs Market Analysis by Applications

      • 6.1 Global Non-prescription Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Non-prescription Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Non-prescription Drugs Business

      • 7.1 Pfizer
        • 7.1.1 Pfizer Non-prescription Drugs Production Sites and Area Served
        • 7.1.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.1.3 Pfizer Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Roche
        • 7.2.1 Roche Non-prescription Drugs Production Sites and Area Served
        • 7.2.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.2.3 Roche Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sanofi
        • 7.3.1 Sanofi Non-prescription Drugs Production Sites and Area Served
        • 7.3.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.3.3 Sanofi Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Johnson & Johnson
        • 7.4.1 Johnson & Johnson Non-prescription Drugs Production Sites and Area Served
        • 7.4.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.4.3 Johnson & Johnson Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Merck & Co. (MSD)
        • 7.5.1 Merck & Co. (MSD) Non-prescription Drugs Production Sites and Area Served
        • 7.5.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.5.3 Merck & Co. (MSD) Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis
        • 7.6.1 Novartis Non-prescription Drugs Production Sites and Area Served
        • 7.6.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.6.3 Novartis Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 AbbVie
        • 7.7.1 AbbVie Non-prescription Drugs Production Sites and Area Served
        • 7.7.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.7.3 AbbVie Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Gilead Sciences
        • 7.8.1 Gilead Sciences Non-prescription Drugs Production Sites and Area Served
        • 7.8.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.8.3 Gilead Sciences Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 GlaxoSmithKline (GSK)
        • 7.9.1 GlaxoSmithKline (GSK) Non-prescription Drugs Production Sites and Area Served
        • 7.9.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.9.3 GlaxoSmithKline (GSK) Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Amgen
        • 7.10.1 Amgen Non-prescription Drugs Production Sites and Area Served
        • 7.10.2 Non-prescription Drugs Product Introduction, Application and Specification
        • 7.10.3 Amgen Non-prescription Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 AstraZeneca
      • 7.12 Bristol-Myers Squibb
      • 7.13 Eli Lilly
      • 7.14 Teva
      • 7.15 Bayer
      • 7.16 Novo Nordisk
      • 7.17 Allergan
      • 7.18 Shire
      • 7.19 Boehringer Ingelheim
      • 7.20 Takeda

      8 Non-prescription Drugs Manufacturing Cost Analysis

      • 8.1 Non-prescription Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Non-prescription Drugs
      • 8.4 Non-prescription Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Non-prescription Drugs Distributors List
      • 9.3 Non-prescription Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Non-prescription Drugs Market Forecast

      • 11.1 Global Non-prescription Drugs Production, Revenue Forecast
        • 11.1.1 Global Non-prescription Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Non-prescription Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Non-prescription Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Non-prescription Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Non-prescription Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Non-prescription Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Non-prescription Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Non-prescription Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Non-prescription Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Non-prescription Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Non-prescription Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Non-prescription Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Non-prescription Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Non-prescription Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Non-prescription Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        A medication (also referred to as medicine, pharmaceutical drug, or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and relies on the science of pharmacology for continual advancement and on pharmacy for appropriate management.

        The global Non-prescription Drugs market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Non-prescription Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Non-prescription Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Pfizer
        Roche
        Sanofi
        Johnson & Johnson
        Merck & Co. (MSD)
        Novartis
        AbbVie
        Gilead Sciences
        GlaxoSmithKline (GSK)
        Amgen
        AstraZeneca
        Bristol-Myers Squibb
        Eli Lilly
        Teva
        Bayer
        Novo Nordisk
        Allergan
        Shire
        Boehringer Ingelheim
        Takeda

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Brand Drugs
        Generic Drug

        Segment by Application
        Hospital
        Clinic
        Other

        Buy now